Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Boston Medical Group vs HydraMed

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Boston Medical Group

Best for budget-conscious shoppers

Starting at $66/mo

CompoundedSemaglutideTirzepatide
Visit Boston Medical Group
7.9

HydraMed

Best for patients wanting all-in pricing with a single intake fee

Starting at $179/mo

CompoundedSemaglutideTirzepatideFree shipping
Visit HydraMed

Side-by-Side Comparison

FeatureBoston Medical GroupHydraMed
Overall Score7.7/107.9/10
Starting Price$66/mo$179/mo
Customer Rating
Features3 features6 features
States Available5050
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Boston Medical Group

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Cons

  • Limited public information on program details

HydraMed

Pros

  • All-inclusive pricing with no add-ons
  • Free shipping
  • US FDA-registered compounding pharmacy
  • Quick intake process

Cons

  • Wide peptide menu beyond GLP-1s — patients should stay focused on FDA-approved indications
  • Trust score moderate pending more independent verification

Our Verdict

Winner: HydraMedScore: 7.9/10

HydraMed edges out Boston Medical Group with a higher overall score of 7.9/10 and is particularly strong for patients wanting all-in pricing with a single intake fee. Boston Medical Group remains a solid alternative, especially if you're looking for budget-conscious shoppers.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.